-
1
-
-
84902551843
-
The selective vasopressin type 1a receptor agonist selepressin (FE 202158) Blocks vascular leak in ovine severe sepsis
-
Maybauer MO, Maybauer DM, Enkhbaatar P, et al: The Selective Vasopressin Type 1a Receptor Agonist Selepressin (FE 202158) Blocks Vascular Leak in Ovine Severe Sepsis. Crit Care Med 2014; 42:e525-e533
-
(2014)
Crit Care Med
, vol.42
-
-
Maybauer, M.O.1
Maybauer, D.M.2
Enkhbaatar, P.3
-
2
-
-
0031026648
-
Vasopressin deficiency contributes to the vasodilation of septic shock
-
Landry DW, Levin HR, Gallant EM, et al: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997; 95:1122-1125
-
(1997)
Circulation
, vol.95
, pp. 1122-1125
-
-
Landry, D.W.1
Levin, H.R.2
Gallant, E.M.3
-
3
-
-
34347383381
-
Vasopressin in vasodilatory and septic shock
-
Russell JA: Vasopressin in vasodilatory and septic shock. Curr Opin Crit Care 2007; 13:383-391
-
(2007)
Curr Opin Crit Care
, vol.13
, pp. 383-391
-
-
Russell, J.A.1
-
4
-
-
84875133181
-
A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock
-
Daley MJ, Lat I, Mieure KD, et al: A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock. Ann Pharmacother 2013; 47:301-310
-
(2013)
Ann Pharmacother
, vol.47
, pp. 301-310
-
-
Daley, M.J.1
Lat, I.2
Mieure, K.D.3
-
5
-
-
3543092016
-
Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock
-
Hall LG, Oyen LJ, Taner CB, et al: Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock. Pharmacotherapy 2004; 24:1002-1012
-
(2004)
Pharmacotherapy
, vol.24
, pp. 1002-1012
-
-
Hall, L.G.1
Oyen, L.J.2
Taner, C.B.3
-
6
-
-
33750201277
-
Vasopressin or norepinephrine in early hyperdynamic septic shock: A randomized clinical trial
-
Lauzier F, Lévy B, Lamarre P, et al: Vasopressin or norepinephrine in early hyperdynamic septic shock: A randomized clinical trial. Intensive Care Med 2006; 32:1782-1789
-
(2006)
Intensive Care Med
, vol.32
, pp. 1782-1789
-
-
Lauzier, F.1
Lévy, B.2
Lamarre, P.3
-
7
-
-
84891608334
-
Receptor-selective vasopressin analogs: A new push for decatecholaminization"?
-
Radermacher P, Thiemermann C: Receptor-selective vasopressin analogs: A new push for "decatecholaminization"? Shock 2013; 39:539-540
-
(2013)
Shock
, vol.39
, pp. 539-540
-
-
Radermacher, P.1
Thiemermann, C.2
-
8
-
-
40049109098
-
Vasopressin versus norepinephrine infusion in patients with septic shock
-
VASST Investigators
-
Russell JA, Walley KR, Singer J, et al; VASST Investigators: Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008; 358:877-887
-
(2008)
N Engl J Med
, vol.358
, pp. 877-887
-
-
Russell, J.A.1
Walley, K.R.2
Singer, J.3
-
9
-
-
84873339299
-
Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012
-
Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup
-
Dellinger RP, Levy MM, Rhodes A, et al; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup: Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41: 580-637
-
(2013)
Crit Care Med
, vol.41
, pp. 580-637
-
-
Dellinger, R.P.1
Levy, M.M.2
Rhodes, A.3
-
10
-
-
31344461826
-
Sepsis in European intensive care units: Results of the SOAP study
-
Sepsis Occurrence in Acutely Ill Patients Investigators
-
Vincent JL, Sakr Y, Sprung CL, et al; Sepsis Occurrence in Acutely Ill Patients Investigators: Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med 2006; 34:344-353
-
(2006)
Crit Care Med
, vol.34
, pp. 344-353
-
-
Vincent, J.L.1
Sakr, Y.2
Sprung, C.L.3
-
11
-
-
78651226079
-
Role of selective V1a receptor agonism in ovine septic shock
-
Rehberg S, Ertmer C, Vincent JL, et al: Role of selective V1a receptor agonism in ovine septic shock. Crit Care Med 2011; 39:119-125
-
(2011)
Crit Care Med
, vol.39
, pp. 119-125
-
-
Rehberg, S.1
Ertmer, C.2
Vincent, J.L.3
-
12
-
-
84902482561
-
123: Early administration of the selective V1a receptor agonist selepressin is superior to arginine vasopressin or norepinephrine in a sheep model of septic shock
-
Su F, He X, Taccone FS, et al. 123: Early administration of the selective V1a receptor agonist selepressin is superior to arginine vasopressin or norepinephrine in a sheep model of septic shock. Crit Care Med 2012; 40:1-328
-
(2012)
Crit Care Med
, vol.40
, pp. 1-328
-
-
Su, F.1
He, X.2
Taccone, F.S.3
-
13
-
-
84869159866
-
Selective V(1a) agonism attenuates vascular dysfunction and fluid accumulation in ovine severe sepsis
-
Rehberg S, Yamamoto Y, Sousse L, et al: Selective V(1a) agonism attenuates vascular dysfunction and fluid accumulation in ovine severe sepsis. Am J Physiol Heart Circ Physiol 2012; 303:123
-
(2012)
Am J Physiol Heart Circ Physiol
, vol.303
, pp. 123
-
-
Rehberg, S.1
Yamamoto, Y.2
Sousse, L.3
|